Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01795092 · ClinicalTrials.gov registry record · NA

A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT01795092: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01795092 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01795092, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

This is a randomized, controlled study to compare patients evaluated by primary care physicians alone versus patients who are additionally evaluated by a dermatologist at the primary care physician"s office, aiming to demonstrate that visits to the primary care physician"s (PCP) office that involve both the PCP and an on-site dermatology consultation will reduce hospital admission rates. The hypothesis of this study is that obtaining outpatient dermatology consultations during a patient"s initial presentation to a primary care office will reduce admissions for cellulitis with accuracy. The primary objective will be to measure the difference in the proportion of patients requiring hospital admission utilizing a dermatology consultation at the PCP"s office (active arm) versus primary care evaluation alone (control arm) by calculating risk ratios and risk differences. The risk of admission for each arm will be assessed once the study has been completed. The secondary endpoint will be admission versus discharge home at a dermatology follow-up visit to assess accuracy of initial assessment. An additional endpoint will be to determine if any differences in frequencies of cellulitis and admission exist based on age and immunosuppression. Exploratory analyses will assess the percentage of patients with a concomitant known predisposing factor for recurrent cellulitis such as lymphedema, leg ulceration, tinea pedis, or onychomycosis, as well as the association of fever \>100.5 F and a history of a prior episode of cellulitis.

Interventions

  • OTHER Dermatology Consultation

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2012-02
Est. Completion 2012-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01795092

The ClinicalTrials.gov registry entry for NCT01795092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dermatology Consultation is the first listed.

NCT01795092 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01795092 about?

NCT01795092 is a clinical study titled "A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis". This is a randomized, controlled study to compare patients evaluated by primary care physicians alone versus patients who are additionally evaluated by a dermatologist at the primary care physician"s office, aiming to demonstrate that visits to the primary care physician"s (PCP) office that involve ...

What is the current status of trial NCT01795092?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2012-02. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01795092?

The interventions under investigation include: Dermatology Consultation (OTHER).

Who is sponsoring clinical trial NCT01795092?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.